AnaptysBio is splitting into a high-margin royalty company and a pipeline-focused biopharma, each with distinct valuation ...
Emerging research suggests milk fever may be less about calcium deficiency and more about how inflammation and metabolism ...
Dyve Biosciences, in collaboration with Moffitt Cancer Center, today reported significant study results for a first-of-its-kind investigational therapy applied to the skin and des ...
For decades, treatment of Parkinson’s disease has centered on replacing dopamine, the neurotransmitter whose decline drives the disease’s hallmark motor symptoms. But while therapies such as levodopa ...
Everyday Health on MSN
Biologics for psoriasis: Are dual inhibitors more effective?
Learn how biologic therapies for psoriasis work, the difference between single and dual inhibitors, and how dermatologists choose the right treatment for the individual.
Researchers analyzing 761 first-trimester pregnancies found that SARS-CoV-2 was rarely detected in placental tissues, ...
Cue Biopharma, Inc. ( CUE) Discusses CUE-401 R&D Progress and Mechanism for Autoimmune and Inflammatory Diseases April 7, 2026 10:00 AM EDT Lucinda Warren - Interim CEO, Interim President,Principal ...
Findings show microplastics in bile may trigger cellular senescence, suggesting a link to gallstone disease and highlighting ...
Right ventricular (RV) remodeling and dysfunction are serious cardiovascular consequences due to prolonged hypoxic exposure, commonly seen in conditions such as chronic lung disease and high-altitude ...
Alarming Link Between Screen Addiction And Brain Aging ...
The effect of tumor necrosis factor–alpha inhibitor exposure on skin cancer risk among patients with inflammatory diseases was examined.
The psoriasis clinical trial analysis report delivers important insights into ongoing research of 100+ pipeline psoriasis ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results